{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:36:54Z","timestamp":1792183014918,"version":"4.4.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Alcoholic liver disease (ALD) is a liver damage disease caused by long-term heavy drinking. Currently, there is no targeted pharmaceutical intervention available for the treatment of this disease. To address this, this paper evaluates the efficacy and safety of probiotic preparation in treating ALD through conducting a meta-analysis, and provides a valuable insight for clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was conducted across databases, including PubMed, Embase, Web of Science, Cochrane Library, CNKI, VIP, Wanfang, and CBM from the inception dates to October 15, 2023, to identify clinical randomized controlled trials on probiotic preparations in the treatment of ALD. After the literature underwent screening, data extraction, and quality assessment, RevMan 5.3 and Stata 14.2 were employed for data analysis and processing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 9 randomized controlled trials fulfilled the inclusion criteria. The results of the meta-analysis showed that probiotic preparation could significantly improve the liver function of patients with alcoholic liver disease compared with the control group. Probiotic intervention led to a significant reduction in the levels of alanine aminotransferase (MD=-13.36,95%CI:-15.80,-10.91;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;0.00001),aspartate aminotransferase (MD=-16.99,95%CI:-20.38,-13.59;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;0.00001),\u03b3-glutamyl transpeptidase (MD=-18.79,95% CI:-28.23,-9.34;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;0.0001). Concurrently, the level of serum albumin (MD=0.19,95% CI:0.02,0.36;\n                      <jats:italic>P<\/jats:italic>\n                      =0.03) was increased. Furthermore, probiotic intervention could also modulate the composition of intestinal flora in patients with alcoholic liver disease, leading to an augmentation in\n                      <jats:italic>Bifidobacteria<\/jats:italic>\n                      and a reduction in\n                      <jats:italic>Escherichia coli.<\/jats:italic>\n                      However, in patients with alcoholic liver disease, probiotic intervention showed no significant effects on total bilirubin (MD=-0.01,95% CI:-0.17,0.15;\n                      <jats:italic>P<\/jats:italic>\n                      =0.91), tumor necrosis factor-\u03b1 (MD=0.03,95% CI:-0.86,0.92;\n                      <jats:italic>P<\/jats:italic>\n                      =0.94) and interleukin-6 (MD=-5.3,95% CI:-16.04,5.45;\n                      <jats:italic>P<\/jats:italic>\n                      =0.33).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The meta-analysis indicates that probiotics can improve liver function in alcoholic liver disease, reduce inflammatory responses, regulate intestinal flora, which have potential value in the treatment of alcoholic liver disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>\n                      , identifier  CRD42023472527.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2024.1358063","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T10:58:05Z","timestamp":1710241085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Shi-Ying","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Rong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42059-3","article-title":"Randomized, double-blind, placebo-controlled study of a multispecies probiotic mixture in nonalcoholic fatty liver disease","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mam.2007.09.004","article-title":"Oxidative mechanisms in the pathogenesis of alcoholic liver disease","volume":"29","author":"Albano","year":"2008","journal-title":"Mol. Aspects Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.17235\/reed.2020.7242\/2020","article-title":"Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments","volume":"112","author":"Argemi","year":"2020","journal-title":"Rev. Esp Enferm Dig"},{"key":"B4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053028","article-title":"Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment","volume":"8","author":"Bull-Otterson","year":"2013","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","article-title":"Alcohol metabolism","volume":"16","author":"Cederbaum","year":"2012","journal-title":"Clin. Liver Dis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-151","article-title":"The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury","volume":"13","author":"Chang","year":"2013","journal-title":"BMC Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the intestinal microbiome and gut barrier to hepatic disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4133417","DOI":"10.1097\/MPG.0000000000001422","article-title":"Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents","volume":"64","author":"Famouri","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13101057","article-title":"Akkermansia muciniphila ameliorates alcoholic liver disease in experimental mice by regulating serum metabolism and improving gut dysbiosis","volume":"13","author":"Fang","year":"2023","journal-title":"Metabolites"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9370565","article-title":"Behavior of oxidative stress markers in alcoholic liver cirrhosis patients","volume":"2016","author":"Galicia-Moreno","year":"2016","journal-title":"Oxid. Med. Cell Longev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9097276","article-title":"Probiotics for alleviating alcoholic liver injury","volume":"2019","author":"Gu","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071474","article-title":"Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis","volume":"10","author":"Gupta","year":"2022","journal-title":"Microorganisms"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","article-title":"Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study","volume":"27","author":"Han","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2165\/00003088-198713050-00001","article-title":"Clinical pharmacokinetics of ethanol","volume":"13","author":"Holford","year":"1987","journal-title":"Clin. Pharmacokinet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0117451","DOI":"10.1371\/journal.pone.0117451","article-title":"Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease","volume":"10","author":"Hong","year":"2015","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.3892\/etm.2019.8123","article-title":"Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model","volume":"18","author":"Huang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrd2505","article-title":"Gut microbiota: a potential new territory for drug targeting","volume":"7","author":"Jia","year":"2008","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B20","doi-asserted-by":"publisher","first-page":"G42","DOI":"10.1152\/ajpgi.00017.2023","article-title":"Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease","volume":"325","author":"Kaufmann","year":"2023","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1039\/C8FO00252E","article-title":"Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-\u03baB activation through restoration of the disturbed gut microbiota","volume":"9","author":"Kim","year":"2018","journal-title":"Food Funct."},{"key":"B22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12072-012-9408-x","article-title":"Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis","volume":"7","author":"Koga","year":"2013","journal-title":"Hepatol. Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/00024382-200202000-00002","article-title":"Heat shock inhibits tnf-induced ICAM-1 expression in human endothelial cells via I kappa kinase inhibition","volume":"17","author":"Kohn","year":"2002","journal-title":"Shock"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.3748\/wjg.v24.i45.5063","article-title":"Alcoholic liver disease: Utility of animal models","volume":"24","author":"Lamas-Paz","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s41430-020-00852-8","article-title":"Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury","volume":"75","author":"Li","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acs.jafc.0c06346","article-title":"Lactobacillus plantarum KLDS1.0344 and Lactobacillus acidophilus KLDS1.0901 Mixture Prevents Chronic Alcoholic Liver Injury in Mice by Protecting the Intestinal Barrier and Regulating Gut Microbiota and Liver-Related Pathways","volume":"69","author":"Li","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12602-022-10005-x","article-title":"Compound probiotic ameliorates acute alcoholic liver disease in mice by modulating gut microbiota and maintaining intestinal barrier","volume":"15","author":"Liu","year":"2023","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B29","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/hep.29887","article-title":"The high burden of alcoholic cirrhosis in privately insured persons in the United States","volume":"68","author":"Mellinger","year":"2018","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1212742","article-title":"Harnessing the potential of probiotics in the treatment of alcoholic liver disorders","volume":"14","author":"Mishra","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2174\/138161208784480234","article-title":"Genomics can advance the potential for probiotic cultures to improve liver and overall health","volume":"14","author":"O\u2019Sullivan","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/a-2145-7331","article-title":"Gut microbiome-centered therapies for alcohol-associated liver disease","volume":"43","author":"Ranjbarian","year":"2023","journal-title":"Semin. Liver. Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nm.4185","article-title":"Signals from the gut microbiota to distant organs in physiology and disease","volume":"22","author":"Schroeder","year":"2016","journal-title":"Nat. Med."},{"key":"B38","first-page":"561","article-title":"Current management of alcohol-associated liver disease","volume":"16","author":"Siddiqi","year":"2020","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","article-title":"Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis","volume":"48","author":"Stadlbauer","year":"2008","journal-title":"J. Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1159\/000324281","article-title":"Gut-liver axis and sensing microbes","volume":"28","author":"Szabo","year":"2010","journal-title":"Dig Dis."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United State-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"Bmj"},{"key":"B44","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1111\/jgh.1998.13.s1.39","article-title":"The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury","volume":"13","author":"Thurman","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s12275-015-5239-5","article-title":"Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding","volume":"53","author":"Tian","year":"2015","journal-title":"J. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.14309\/ajg.0000000000002283","article-title":"The beneficial effects of lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis","volume":"118","author":"Vatsalya","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines5040050","article-title":"Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes","volume":"5","author":"Vitetta","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1054265","article-title":"Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Nutr."},{"key":"B49","volume-title":"Global status report on alcohol and health 2018","year":"2018"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1097\/MEG.0b013e32833eb8b0","article-title":"Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis","volume":"22","author":"Zhang","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3760\/cma.j.issn.1673-4777.2011.05.020","article-title":"The therapeutic role of liver combined Bifidobacterium,lactobacillus and enterococcus in alcoholic liver disease","volume":"6","author":"Zhang","year":"2011","journal-title":"China Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.13381\/j.cnki.cjm.201901018","article-title":"Influence of Clostridium Butyricum Tablets Combined with Polyene Phosphatidyl Choline on intestinal flora and inflammatory factors of patients with alcoholic liver disease","volume":"31","author":"Zhu","year":"2019","journal-title":"Chin. J. Microecology"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1358063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T10:58:14Z","timestamp":1710241094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1358063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":52,"alternative-id":["10.3389\/fcimb.2024.1358063"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1358063","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"article-number":"1358063"}}